$Amgen(AMGN)$ $Amgen Inc. (AMGN) Rises +1.96%: Biotech Giant Rebounds from Support, Eyes $349 Resistance π Latest Close (2026-05-20): $330.75 (+$6.36, +1.96%). The stock is now ~15.5% below its 52-week high of $391.29. π‘ Core Market Drivers: Regulatory Headwind Fades: The stock is recovering from a recent sell-off triggered by the FDA's recommendation to revoke approval for Tavneos (April 30th). The market appears to be digesting this news. Strong Financial Guidance: The company's 2026 adjusted EPS forecast of $21.70-$23.10 (vs. FactSet consensus of $22.16) provides a solid earnings anchor. Macro & Sentiment: Broad market strength and a rotation into stable, dividend-paying large-caps may be providing support. π¬ Technical Analysis: Volume: Tra